The COVID-19 vaccine called \u2018AZD1222<\/strong>\u2019 developed by Oxford University and AstraZeneca has shown promising results against coronavirus infection.<\/p>\n The encouraging results came at a time when global countries such as the US, India and Brazil are continuously the highest single-day spike in coronavirus cases.<\/p>\n So far, around 14.8 million people worldwide are infected and 613,335 lost their lives due to coronavirus.<\/p>\n The phase-1 and phase-2 vaccine trails have induced a strong immune response and showed no adverse reaction among the 1,077 participants.<\/p>\n